Cochlear Future Growth
Future criteria checks 3/6
Cochlear is forecast to grow earnings and revenue by 12.2% and 8.4% per annum respectively. EPS is expected to grow by 12.2% per annum. Return on equity is forecast to be 24.5% in 3 years.
Key information
12.2%
Earnings growth rate
12.2%
EPS growth rate
| Medical Equipment earnings growth | 16.7% |
| Revenue growth rate | 8.4% |
| Future return on equity | 24.5% |
| Analyst coverage | Good |
| Last updated | 10 Apr 2024 |
Recent future growth updates
Recent updates
Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively
Mar 27
Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching
Feb 21Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively
Dec 18Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value
Oct 04Cochlear (ASX:COH) Could Be Struggling To Allocate Capital
Sep 12Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital
Jun 05Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly
Apr 05Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital
Mar 04Is Cochlear (ASX:COH) A Risky Investment?
Dec 19Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?
Nov 16The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence
Oct 25Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?
Oct 11Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's
Aug 28Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly
Aug 23The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence
Jul 16A Look At The Fair Value Of Cochlear Limited (ASX:COH)
May 19Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal
Apr 09Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)
Feb 04Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal
Dec 24Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly
Oct 30This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders
Oct 12A Look At The Fair Value Of Cochlear Limited (ASX:COH)
Oct 06Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)
Aug 16Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet
Jun 24A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)
May 17There Are Reasons To Feel Uneasy About Cochlear's (ASX:COH) Returns On Capital
Apr 29These 4 Measures Indicate That Cochlear (ASX:COH) Is Using Debt Reasonably Well
Mar 20Insider Buying: The Cochlear Limited (ASX:COH) Independent Non-Executive Director Just Bought 24% More Shares
Mar 02Cochlear Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Feb 20Calculating The Intrinsic Value Of Cochlear Limited (ASX:COH)
Feb 11Our Take On The Returns On Capital At Cochlear (ASX:COH)
Jan 25Do Institutions Own Cochlear Limited (ASX:COH) Shares?
Jan 07Introducing Cochlear (ASX:COH), The Stock That Zoomed 107% In The Last Five Years
Dec 21
How Much Is Cochlear Limited (ASX:COH) CEO Getting Paid?
Dec 06Does Cochlear (ASX:COH) Have A Healthy Balance Sheet?
Nov 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2026 | 2,700 | 503 | 486 | 590 | 15 |
| 6/30/2025 | 2,495 | 444 | 417 | 521 | 16 |
| 6/30/2024 | 2,276 | 392 | 354 | 449 | 16 |
| 12/31/2023 | 2,149 | 350 | 335 | 430 | N/A |
| 9/30/2023 | 2,043 | 326 | 301 | 396 | N/A |
| 6/30/2023 | 1,936 | 301 | 267 | 362 | N/A |
| 3/31/2023 | 1,824 | 281 | 263 | 352 | N/A |
| 12/31/2022 | 1,713 | 261 | 259 | 341 | N/A |
| 9/30/2022 | 1,681 | 275 | 279 | 359 | N/A |
| 6/30/2022 | 1,648 | 289 | 299 | 377 | N/A |
| 3/31/2022 | 1,612 | 273 | 266 | 340 | N/A |
| 12/31/2021 | 1,575 | 257 | 233 | 304 | N/A |
| 9/30/2021 | 1,536 | 291 | 216 | 285 | N/A |
| 6/30/2021 | 1,498 | 324 | 199 | 265 | N/A |
| 3/31/2021 | 1,403 | 82 | -52 | 34 | N/A |
| 12/31/2020 | 1,308 | -160 | -302 | -198 | N/A |
| 9/30/2020 | 1,314 | -199 | -295 | -178 | N/A |
| 6/30/2020 | 1,321 | -238 | -288 | -158 | N/A |
| 3/31/2020 | 1,400 | 34 | -80 | 50 | N/A |
| 12/31/2019 | 1,479 | 306 | 128 | 259 | N/A |
| 9/30/2019 | 1,453 | 291 | 155 | 277 | N/A |
| 6/30/2019 | 1,427 | 277 | 181 | 296 | N/A |
| 3/31/2019 | 1,422 | 270 | 217 | 313 | N/A |
| 12/31/2018 | 1,418 | 264 | 252 | 330 | N/A |
| 9/30/2018 | 1,391 | 255 | 230 | 294 | N/A |
| 6/30/2018 | 1,364 | 246 | 208 | 258 | N/A |
| 3/31/2018 | 1,329 | 234 | 194 | 254 | N/A |
| 12/31/2017 | 1,294 | 223 | 180 | 250 | N/A |
| 9/30/2017 | 1,274 | 223 | N/A | 255 | N/A |
| 6/30/2017 | 1,254 | 224 | N/A | 260 | N/A |
| 3/31/2017 | 1,218 | 215 | N/A | 237 | N/A |
| 12/31/2016 | 1,182 | 206 | N/A | 214 | N/A |
| 9/30/2016 | 1,156 | 198 | N/A | 199 | N/A |
| 6/30/2016 | 1,131 | 189 | N/A | 185 | N/A |
| 3/31/2016 | 1,088 | 179 | N/A | 179 | N/A |
| 12/31/2015 | 1,045 | 168 | N/A | 172 | N/A |
| 9/30/2015 | 986 | 157 | N/A | 181 | N/A |
| 6/30/2015 | 926 | 146 | N/A | 189 | N/A |
| 3/31/2015 | 899 | 145 | N/A | 178 | N/A |
| 12/31/2014 | 872 | 144 | N/A | 168 | N/A |
| 9/30/2014 | 839 | 119 | N/A | 140 | N/A |
| 6/30/2014 | 805 | 94 | N/A | 111 | N/A |
| 3/31/2014 | 769 | 85 | N/A | 93 | N/A |
| 12/31/2013 | 732 | 76 | N/A | 75 | N/A |
| 9/30/2013 | 742 | 104 | N/A | 72 | N/A |
| 6/30/2013 | 753 | 133 | N/A | 70 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COH's forecast earnings growth (12.2% per year) is above the savings rate (2.2%).
Earnings vs Market: COH's earnings (12.2% per year) are forecast to grow slower than the Australian market (13.9% per year).
High Growth Earnings: COH's earnings are forecast to grow, but not significantly.
Revenue vs Market: COH's revenue (8.4% per year) is forecast to grow faster than the Australian market (5.1% per year).
High Growth Revenue: COH's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: COH's Return on Equity is forecast to be high in 3 years time (24.5%)